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Ⅰ New biotechnology and enhancement
Embryo screening or sperm-sorting, the
use of growth hormone, Ritalin and Prozac,
not to mention Botox, Viagra, and anabolic
steroids―many of these new biotechnologies
were originally developed to help those in
need of healing. These days, however, they
are widely used to help satisfy various de-
sires. Also, drugs to flatten the emotional
tone of painful or shameful memories, genes
to increase the size and strength of muscles,
nano-mechanical implants to enhance sensa-
tion or motor skills, and perhaps techniques
to slow biological aging and increase the
maximum human lifespan seem to be coming
soon.
I would like to name the uses of new
technologies in non-therapeutic or desire-sat-
isfying ways “enhancement”. And I would
like here to define the terms “therapy” and
“enhancement” as follows, in line with the
President’s Council on Bioethics’ report Be-
yond Therapy, 2003. Therapy is the use of
biotechnical power to treat individuals with
known diseases, disabilities, or impairments,
in an attempt to restore them to a normal
state of health and fitness. Enhancement is
the direct use of biotechnical power to alter,
by direct intervention, not disease processes
but the “normal” workings of the human
body and psyche, to augment or improve
their native capacities and performance .
Such uses of new biomedical technolo-
gies beyond therapy are now widely ac-
cepted : pills for sleep and wakefulness,
weight loss, hair growth, and birth control ;
surgery to remove fat and wrinkles, to
shrink thighs, and enlarge breasts ; and pro-
cedures to straighten teeth and to select the
sex of offspring. Let’s take up some exam-
ples of the use of the new technologies in de-
sire-satisfying ways. In 2002, Americans
spent roughly one billion dollars on drugs
used to treat baldness, about ten times the
amount spent on scientific research to find a
cure for malaria, a disease that afflicts hun-
dreds of millions of people worldwide. Ac-
Subjectivity in the Age of Biotechnology
Takeshi Kuramochi（Matsumoto Dental University）
（２００６年１１月３０日受理．）
１
cording to the American Society for Aes-
thetic Plastic Surgery, Americans also spent
7.7 billion dollars on 6.9 million cosmetic pro-
cedures, more than triple the number in 1997
(2.1 million). And the annual production quo-
tas for the stimulant drug “Ritalin” almost
tripled between 1992 and 1995, and doubled
again between 1995 and 2002. The 2002
quota of 20,967 kg is sufficient to produce a
little over one billion Ritalin pills containing
20 mg of methylphenidate .
Ⅱ The “dual use” of the same technology
The same technology can be used du-
ally. For example,
Thus, enhancement is the biotechnologi-
cal form of human empowerment. By means
of its techniques (for example, recombining
genes), instruments (for example, DNA se-
quencers), and products (for example, new
drugs or vaccines), biotechnology empowers
us human beings to assume greater control
over our lives, diminishing our subjection to
disease and misfortune, chance and neces-
sity.
Ⅲ Some problems spawned by
enhancement
Many of the problems derived from en-
hancement are complicated. What exactly is
it about the lot of humankind that needs or
invites improvement? What exactly is it
about “man’s estate” that most calls for re-
lief? Must “improvement” be limited to elimi-
nating these or other evils, or should it also
encompass augmenting our share of positive
goods―beauty, strength, memory, intelli-
gence, longevity, or happiness itself?
Technique Therapy Beyond Therapy
１） to test early human em-
bryos for the presence and
absence of many genes
to prevent disease to try to get us “better” chil-
dren
２） to boost muscle strength
and performance
to treat muscular dystrophy
and the weak muscles of the
elderly
to enable athletes to attain su-
perior performance
３） to control the biological
processes of aging
to diminish the bodily and men-
tal infirmities of old age
to engineer large increases in
the maximum human lifespan
４） to alter mental life, includ-
ing memory and mood
to prevent or treat mental ill-
ness
to blunt painful or shameful be-
havior, transform a melancholic
temperament, or erase the sor-
rows of mourning
５） to use ingenious nano-tech-
nological devices, implant-
able into the human body
and brain
to overcome blindness and
deafness
to enhance native human ca-
pacities of awareness and ac-
tion
２
The problems touch on the end and
goals to be served by the acquisition of
biotechnical power, not just on the safety, ef-
ficacy, or morality of the means. They bear
on the nature and meaning of human free-
dom and human flourishing. They face
squarely the alleged threat of dehumaniza-
tion as well as the alleged promise of “super-
humanization.” And they compel attention to
what it means to be a human being and to be
active as a human being. So they are beyond
such familiar issues of bioethics as informed
consent for human subjects of research, equi-
table access to the fruits of medical research,
and the morality of the means used to pur-
sue worthy ends. In short, enhancement
bears upon the dreams of human perfection,
namely aspirations to overcome common hu-
man limitations and individual shortfalls in
native endowment.
Some give optimistic views. For exam-
ple, James Watson, co-discoverer of the
structure of DNA, takes that if we could
make better human beings by knowing how
to add genes, why shouldn’t we? And the
National Science Foundation 2003 report de-
clares : “At this unique moment in the his-
tory of technical achievement, improvement
of human performance becomes possible,
and such improvement, if pursued with
vigor, could achieve a golden age that would
be a turning point for human productivity
and quality of life.” They draw a picture of
the world whose citizens―biologically better
equipped, aided by performance-enhancers,
liberated from the constraints of nature and
fortune―are longer lived, more competent,
better accomplished, more productive, and
happier than human beings have ever been
before. Yet, precisely because the new
knowledge and the new powers impinge di-
rectly upon the human person, and in ways
that may affect our very humanity, a certain
vague disquiet hovers over the entire enter-
prise.
Such concerns can and have been raised
about each of the following : the safety of the
techniques ; the fairness and equality of ac-
cess to the benefits ; the fairness of advan-
tage and authenticity of performance ; overt
or subtle coercion ; the misuse of society’s
precious medical resources ; the increasing
medicalization of human activities ; the ma-
nipulation of desires ; the possible hubris in
trying to improve upon human nature ; and
the consequences for character of getting re-
sults “the easy way” through biotechnology,
without proper effort or discipline. Among
them, Leon R. Kass, the Chairman of the
President’s Council of Bioethics, takes most
essential the concern about the dehumaniza-
tion or self-alienation. He says, “as the power
to transform our native powers increases,
both in magnitude and refinement, so does
the possibility for ‘self-alienation’―for losing,
confounding, or abandoning our identity. I
may get better, stronger, and happier―but I
know not how. I am no longer the agent of
self-transformation, but a passive patient of
transforming powers. ‘Personal achieve-
ments’ impersonally achieved are not truly
the achievement of the persons .”
Ⅳ How to solve the problems?
The concerns about hubris, hyper-
agency, or “man playing God” which repre-
３
sents a false understanding of, and an im-
proper disposition toward, the naturally
given world seem to be solved by the respect
for the given. Yet the respectful attitude to-
ward the given, while both necessary and de-
sirable as a restraint, is not by itself sufficient
as a guide. The giftedness of nature also in-
cludes smallpox and malaria, cancer and Al-
zheimer disease as well as decline and decay.
Moreover, nature is not equally generous
with her gifts, even to man, the most gifted
of her creatures. Modesty born of gratitude
for the world’s “givenness” may enable us to
recognize that not everything in the world is
open to any use we may desire or devise, but
it will not by itself teach us which things can
be tinkered with and which should be left in-
violate. Respect for the giftedness of things
cannot tell us which gifts are to be accepted
as is, which are to be improved through use
or training, which are to be improved house-
broken through self-command or medication,
and which opposed like the plague. So, to
guide the proper use of biomedical power,
we need something in addition to a general-
ized appreciation for nature’s gift .
What is the something precious in our
given nature, beyond the fact of its gifted-
ness? What is the something inherently good
or dignified about the ways in which we en-
gage the world?
I can present here only a conclusion. It is
the rational knowledge of morality, not ordi-
nary but philosophical in Kantian terms. In
“Beyond Therapy,” the President’s Council
attaches importance to morality. But the mo-
rality the council attaches is ordinary, sub-
jective, hypothetical, pragmatic, empirical,
and heteronomous. It is based on the princi-
ple of moral feeling that Kant classes with
that of happiness, because every empirical
principle promises a contribution to our well-
being. Also, the hypothetical morality never
tells us what the best is for us objectively.
We should take a different way from that of
the President’s Council. We ought to comply
with the practical imperative ordered by our
own practical reason. We ought to act in
such a way that we always treat humanity,
whether in our own person or in the person
of any other, never simply as a means, but al-
ways at the same time as an end.
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